Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells.

Therapeutic advances in hematology(2022)

引用 0|浏览28
暂无评分
摘要
Our findings support the use of EP in cases where hematopoiesis is defective, despite its well-known direct effects on hematopoietic cells. Our findings suggest that further studies on the effects of EP on MSCs from patients with aplastic anemia are warranted.
更多
查看译文
关键词
Aplasia,Eltrombopag,Hematopoiesis,MSC,Mesenchymal stem cells
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要